Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North America
- 1st Edition, Volume 52-3 - July 27, 2023
- Imprint: Elsevier
- Editors: Joseph M. Pappachan, Sherouk Fouda
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 4 0 7 - 9
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 4 0 8 - 6
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of… Read more
Purchase options
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.
-
Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more.
-
Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Endocrinologists
Pathobiology of Metabolic-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence
Lean Metabolic-Associated Fatty Liver Disease
Lipid Disorders and Metabolic-Associated Fatty Liver Disease
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota
Metabolic-Associated Fatty Liver Disease and Sarcopenia
A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic[1]Associated Fatty Liver Disease
Pregnancy and Metabolic-Associated Fatty Liver Disease
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome
Management of Metabolic-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence
Lean Metabolic-Associated Fatty Liver Disease
Lipid Disorders and Metabolic-Associated Fatty Liver Disease
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota
Metabolic-Associated Fatty Liver Disease and Sarcopenia
A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic[1]Associated Fatty Liver Disease
Pregnancy and Metabolic-Associated Fatty Liver Disease
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome
Management of Metabolic-Associated Fatty Liver Disease
- Edition: 1
- Volume: 52-3
- Published: July 27, 2023
- Imprint: Elsevier
- Language: English
JP
Joseph M. Pappachan
Professor Pappachan M Joseph is a senior consultant Endocrinologist in the UK and honorary professor at the Manchester Metropolitan University, UK & Manipal University, India. He is an associate editor to Frontiers in Clinical Diabetes & Healthcare, the World Journal of Diabetes, Current Drug Safety, and TouchREVIEWS in Endocrinology. He is also in the editorial board member to JCEM Case Reports (American Endocrine Society) & Scientific Reports (Nature.com). He has fully edited multiple journal issues in the past, and is the lead editor to Elsevier Textbooks: “Endocrine Hypertension: From Basic Science to Clinical Practice” - 2022 and "Metabolic Dysfunction-Associated Fatty Liver Disease" (Endocrine & Metabolism Clinics) - 2023. He has more than 200 scientific publications in his credit in peer reviewed journals/textbooks and has several multinational research collaborations including the Cochrane Metabolic & Endocrine Disorders Group. His academic h-index is 45 with more than 6500 citations of his works to date. His clinical and academic excellence was recognised by the National Clinical Impact Award of the British Government in 2024. His research special interests include obesity, metabolic disorders including MAFLD, neuroendocrinology & parathyroid disorders.
Affiliations and expertise
Department of Endocrinology, Countess of Chester Hospitals NHS Trust; Faculty of Science, Manchester Metropolitan University, UK; Department of Endocrinology Kasturba Medical College, Manipal & Manipal University of Higher Education, Manipal, IndiaSF
Sherouk Fouda
Affiliations and expertise
School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia